July 27, 2018
Bulletin interne de l'Institut Pasteur
Benefits of early antiretroviral therapy in HIV-infected children
The initial findings of the ANRS CLEAC study coordinated by Pierre Frange (Hôpital Necker – AP-HP), help define the immunological and virological benefits of early antiretroviral therapy in HIV-infected children living in France. The results of this study will be presented by Florence Buseyne (Oncogenic Virus Epidemiology & Pathophysiology Team - Institut Pasteur) this Wednesday, 25 July at the 22nd International AIDS Conference (AIDS 2018) being held in Amsterdam from 23 to 26 July 2018.